The overall goal of the GenPath Africa project is to harness the full potential of genomic sequencing by applying it to diagnosis, monitoring and clinical management of current and emerging pathogens.
The project will use genomic sequencing to combat drug-resistant HIV-1 and tuberculosis, and apply recent developments in wastewater surveillance to detect emerging pathogens in human and animal populations. GenPath Africa will also provide in-depth training in genomic sequencing to African scientists and facilitate the transfer of technology to the National Public Health Institute of Mozambique and the South African National Health Laboratory Service. The project endeavours to expand genomic sequencing capacities in Africa and combine genomic epidemiology with precision medicine and public health decision making, thus enabling a better response to current and future pandemics.
GenPath Africa is part of the GenEpi Network, which consists of six projects funded through the topic GH-EDCTP3-2022-CALL1-01-03 and connects them with ongoing BMGF-funded initiatives.
Genomic surveillance to control pathogen infections in Africa
Global Health EDCTP3, BMGF
1 May 2023 – 30 April 2027 (48 months)
4,999,170.25 EUR
Prof. Tulio de Oliveira, Stellenbosch University (SU)
5 partners (GenPath Africa) and 49 partners, respectively (EDCTP3 funded projects in the GenEpi Network) from Africa and Europe